MRFAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.1371999997809E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.68150000274304E-08 |
Normal-vs-Stage2 |
4.08709999999424E-06 |
Normal-vs-Stage3 |
1.09130000003343E-06 |
Normal-vs-Stage4 |
8.565800E-04 |
Stage1-vs-Stage2 |
5.876800E-01 |
Stage1-vs-Stage3 |
2.479400E-01 |
Stage1-vs-Stage4 |
9.570000E-01 |
Stage2-vs-Stage3 |
6.669000E-01 |
Stage2-vs-Stage4 |
7.170800E-01 |
Stage3-vs-Stage4 |
5.119200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.21120000029507E-07 |
Normal-vs-AfricanAmerican |
2.30980000015535E-07 |
Normal-vs-Asian |
4.408300E-04 |
Caucasian-vs-AfricanAmerican |
5.253800E-01 |
Caucasian-vs-Asian |
3.183000E-01 |
AfricanAmerican-vs-Asian |
3.726400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.45599999834545E-08 |
Normal-vs-Female |
1.436050E-04 |
Male-vs-Female |
1.808430E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.76262000000094E-05 |
Normal-vs-Extreme_Weight |
1.11950000047933E-07 |
Normal-vs-Obese |
3.97309999999873E-05 |
Normal-vs-Extreme_Obese |
1.756710E-04 |
Normal_Weight-vs-Extreme_Weight |
9.907000E-01 |
Normal_Weight-vs-Obese |
6.066400E-01 |
Normal_Weight-vs-Extreme_Obese |
7.204800E-01 |
Extreme_Weight-vs-Obese |
5.388400E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.179200E-01 |
Obese-vs-Extreme_Obese |
4.990200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.782900E-03 |
Normal-vs-Age(41-60Yrs) |
2.97549999972446E-07 |
Normal-vs-Age(61-80Yrs) |
1.9059000000432E-07 |
Normal-vs-Age(81-100Yrs) |
4.026000E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.471600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.446600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.421200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.637000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.919000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.663200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.58140000042317E-07 |
Normal-VS-Type2 PRCC |
2.61300003856491E-09 |
Normal-VS-KIRP CIMP |
3.22939999997107E-06 |
Normal-VS-Unclassified PRCC |
9.59470000000406E-05 |
Type1 PRCC-VS-Type2 PRCC |
1.049800E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.049640E-01 |
Type1 PRCC-VS-Unclassified PRCC |
7.847400E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.133200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.326250E-01 |
KIRP CIMP-VS-Unclassified PRCC |
5.359500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.31770003189524E-09 |
Normal-vs-N1 |
1.335340E-03 |
Normal-vs-N2 |
4.349600E-02 |
N0-vs-N1 |
4.339800E-01 |
N0-vs-N2 |
4.650000E-01 |
N1-vs-N2 |
8.801200E-01 |
|
|